Laurion Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-270,000
Closed -$21.9M 559
2023
Q4
$21.9M Buy
+270,000
New +$21M 0.19% 108
2022
Q1
Sell
-140,000
Closed -$10.2M 602
2021
Q4
$10.2M Hold
140,000
0.1% 130
2021
Q3
$9.78M Buy
+140,000
New +$9.84M 0.04% 276
2020
Q1
Sell
-124,200
Closed -$8.07M 883
2019
Q4
$8.07M Sell
124,200
-471,400
-79% -$30.7M 0.06% 248
2019
Q3
$37.7M Buy
595,600
+84,500
+17% +$5.52M 0.28% 83
2019
Q2
$34.5M Buy
+511,100
New +$33.6M 0.34% 74
2019
Q1
Sell
-186,800
Closed -$11.7M 1009
2018
Q4
$11.7M Sell
186,800
-53,500
-22% -$3.74M 0.21% 132
2018
Q3
$18.6M Buy
240,300
+116,800
+95% +$8.82M 0.18% 127
2018
Q2
$8.75M Hold
123,500
0.07% 245
2018
Q1
$9.31M Sell
123,500
-577,500
-82% -$45.9M 0.08% 242
2017
Q4
$50.2M Hold
701,000
0.25% 86
2017
Q3
$56.8M Sell
701,000
-23,600
-3% -$1.8M 0.25% 66
2017
Q2
$51.3M Buy
724,600
+5,200
+0.7% +$346K 0.28% 72
2017
Q1
$48.9M Buy
719,400
+619,400
+619% +$43.6M 0.37% 61
2016
Q4
$7.16M Sell
100,000
-126,000
-56% -$9.37M 0.07% 282
2016
Q3
$17.9M Buy
226,000
+126,000
+126% +$10.2M 0.17% 138
2016
Q2
$8.34M Buy
+100,000
New +$8.87M 0.13% 190
2013
Q4
Sell
-63,000
Closed -$3.96M 234
2013
Q3
$3.96M Buy
+63,000
New +$3.77M 0.29% 78

Other funds holding GILD

Laurion Capital Management's GILD Position: Q1 2026 in Review

Laurion Capital Management opened a new position in Gilead Sciences (GILD) in Q1 2026: 17,812 shares worth $2.48M. The stake represents 0.11% of the portfolio and ranks #190 among its holdings. This is a return to the name: Laurion Capital Management previously reported a position in GILD as recently as Q3 2025.

Laurion Capital Management first reported a position in GILD in Q4 2015 and has held it in 23 quarters since. The position peaked at $18.7M in Q1 2016. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Laurion Capital Management held 17,812 shares of Gilead Sciences worth $2.48M as of Q1 2026.
  • Gilead Sciences was a new Laurion Capital Management position in Q1 2026.
  • Gilead Sciences made up 0.11% of Laurion Capital Management's portfolio in Q1 2026, its #190 holding.
  • Laurion Capital Management first reported a position in Gilead Sciences in Q4 2015 and has held it in 23 quarters since.
  • Laurion Capital Management's Gilead Sciences position peaked at $18.7M in Q1 2016.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.